117 related articles for article (PubMed ID: 17547089)
1. [Mechanism of action of insulin sensitizer agents in the treatment of polycystic ovarian syndrome].
Galindo García CG; Vega Arias Mde J; Hernández Marín I; Ayala AR
Ginecol Obstet Mex; 2007 Mar; 75(3):148-54. PubMed ID: 17547089
[TBL] [Abstract][Full Text] [Related]
2. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance.
Nawrocka J; Starczewski A
Gynecol Endocrinol; 2007 Apr; 23(4):231-7. PubMed ID: 17505944
[TBL] [Abstract][Full Text] [Related]
3. [Insulin sensitizers in the treatment of polycystic ovary].
Ortiz Núñez DA; Hernández Marín I; Ayala AR
Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
[TBL] [Abstract][Full Text] [Related]
4. Drug treatments for polycystic ovary syndrome.
Radosh L
Am Fam Physician; 2009 Apr; 79(8):671-6. PubMed ID: 19405411
[TBL] [Abstract][Full Text] [Related]
5. Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.
Pasquali R; Gambineri A
Expert Opin Ther Targets; 2009 Oct; 13(10):1205-26. PubMed ID: 19650762
[TBL] [Abstract][Full Text] [Related]
6. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
[TBL] [Abstract][Full Text] [Related]
7. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.
Diamanti-Kandarakis E; Economou FN; Livadas S; Tantalaki E; Piperi C; Papavassiliou AG; Panidis D
Kidney Blood Press Res; 2009; 32(1):24-31. PubMed ID: 19212122
[TBL] [Abstract][Full Text] [Related]
8. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
9. Insulin-sensitizing agents in women with polycystic ovary syndrome.
Pasquali R; Gambineri A
Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
[TBL] [Abstract][Full Text] [Related]
10. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
12. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
Practice Committee of American Society for Reproductive Medicine
Fertil Steril; 2008 Nov; 90(5 Suppl):S69-73. PubMed ID: 19007650
[TBL] [Abstract][Full Text] [Related]
13. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
14. Ovulation induction in polycystic ovary syndrome.
Nader S
Minerva Ginecol; 2008 Feb; 60(1):53-61. PubMed ID: 18277352
[TBL] [Abstract][Full Text] [Related]
15. Use of insulin sensitizers in polycystic ovarian syndrome.
Baillargeon JP
Curr Opin Investig Drugs; 2005 Oct; 6(10):1012-22. PubMed ID: 16259222
[TBL] [Abstract][Full Text] [Related]
16. [Clinical effects of metformin in patients with polcystic ovarian syndrome].
Galindo CG; Hernández I; Ayala AR
Ginecol Obstet Mex; 2007 Apr; 75(4):181-6. PubMed ID: 17849796
[TBL] [Abstract][Full Text] [Related]
17. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
Glueck CJ; Goldenberg N; Sieve L; Wang P
Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
[TBL] [Abstract][Full Text] [Related]
18. Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients.
Palomba S; Falbo A; Orio F; Zullo F
Curr Opin Obstet Gynecol; 2008 Aug; 20(4):364-73. PubMed ID: 18660688
[TBL] [Abstract][Full Text] [Related]
19. The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence.
Leeman L; Acharya U
J Obstet Gynaecol; 2009 Aug; 29(6):467-72. PubMed ID: 19697191
[TBL] [Abstract][Full Text] [Related]
20. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
